No insider purchase over the last 90 days. The latest, by Santelli Anthony II, was filed 03 May 2022.
Blue Biofuels, Inc. belongs to the Chemicals sector. Filings by its managers are published through SEC (Form 4). 2 insiders have disclosed 9 filings since 24 October 2025.
No insider bought on the market over the period, while 1 insider filed 7 sales totalling €142k. The largest single trade was a sale of €54k by Kneppers Chris J, published on 3 September 2026, equal to 0.19% of the market capitalisation.
Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
For context, the typical company on the same exchange (median of 282 companies) published 8 filings over the same period, against 9 filings here. Our records for Blue Biofuels, Inc. go back to 2014, with 98 purchases and 133 sales on the open market in total.
In the same sector, recent insider purchases at Titan and Norske Skog ASA also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 269 declarations
Blue Biofuels, Inc. is a company focused on producing biofuels from renewable feedstocks. It operates on the XNAS market and emphasizes sustainable solutions for the energy industry.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 9 filings published between 3 September and 22 October 2026: 7 sales for €142k. 2 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers). Largest amounts: Kneppers Chris J (Director), sales of €142k.
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 23 October 2026 (UTC)